Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-11

Clinical Trial Update: PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing PCI treatment with gemcitabine plus chemotherapy versus chemotherapy alone in patients with inoperable extrahepatic bile duct c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine (Gemcitabine)
  • PCI Treatment

Snippet

Sponsor: PCI Biotech AS | Conditions: Cholangiocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2023-09-11